Akebia Ther
Price & Volume
Stats
See moreOpen | $2.67 |
Previous Close | $2.68 |
Day Range | $2.66-$2.71 |
52W Range | $1.25-$4.07 |
Market Cap | $726.4M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $203.7M |
Revenue Growth (YoY) | 43.1% |
Gross Profit (12 Mos) | $169.5M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • yesterday
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 30 days ago
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Akebia GAAP EPS of $0.00 beats by $0.02, revenue of $62.47M beats by $15.23M
Yahoo Finance • 2 months ago
Akebia Therapeutics (AKBA) Kidney Therapy Vafseo Gaining Market Share
About
CEO | Mr. John P. Butler MBA |
CFO | Mr. Erik John Ostrowski M.B.A. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 181 |
